GM MED SOLUTIONS LIMITED

Company Registration Number:
06996951 (England and Wales)

Unaudited abridged accounts for the year ended 30 September 2023

(Dormant)

Period of accounts

Start date: 01 October 2022

End date: 30 September 2023

GM MED SOLUTIONS LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

GM MED SOLUTIONS LIMITED

Company Information

for the Period Ended 30 September 2023




Director: Greg Medalla
Secretary: Greg Medalla
Registered office: 89
Cowslip Bank
Lychpit
Basingstoke
Hampshire
RG24 8RR
Company Registration Number: 06996951 (England and Wales)

GM MED SOLUTIONS LIMITED

Directors' Report Period Ended 30 September 2023

The directors present their report with the financial statements of the company for the period ended 30 September 2023

Directors

The directors shown below have held office during the whole of the period from 01 October 2022 to 30 September 2023
Greg Medalla

The company was dormant and did not trade in the period.

Secretary
Greg Medalla

This report was approved by the board of directors on 2 September 2024
And Signed On Behalf Of The Board By:

Name: Greg Medalla
Status: Director

GM MED SOLUTIONS LIMITED

Profit and Loss Account

for the Period Ended 30 September 2023

The company was dormant and did not trade in the period. The company received no income and incurred no expenditure in the period and therefore did not make either a profit or loss.

GM MED SOLUTIONS LIMITED

Balance sheet

As at 30 September 2023


Notes

2023
£

2022
£
Fixed assets
Total fixed assets: - -
Current assets
Stocks: 1 1
Cash at bank and in hand: 168,725 166,985
Total current assets: 168,726 166,986
Net current assets (liabilities): 168,726 166,986
Total assets less current liabilities: 168,726 166,986
Total net assets (liabilities): 168,726 166,986

The notes form part of these financial statements

GM MED SOLUTIONS LIMITED

Balance sheet continued

As at 30 September 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 168,726 166,986
Shareholders funds: 168,726 166,986

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 30 September 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 2 September 2024
And Signed On Behalf Of The Board By:

Name: Greg Medalla
Status: Director

The notes form part of these financial statements

GM MED SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GM MED SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 1 1

GM MED SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2023

  • 3. Off balance sheet disclosure

    No